525 related articles for article (PubMed ID: 23401435)
1. Harnessing the immune system for the treatment of non-small-cell lung cancer.
Brahmer JR
J Clin Oncol; 2013 Mar; 31(8):1021-8. PubMed ID: 23401435
[TBL] [Abstract][Full Text] [Related]
2. Active immunotherapy for non-small-cell lung cancer: moving toward a reality.
Perez CA; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.
Anagnostou VK; Brahmer JR
Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for the treatment of non-small cell lung cancer: investigational approaches and clinical experience.
Mellstedt H; Vansteenkiste J; Thatcher N
Lung Cancer; 2011 Jul; 73(1):11-7. PubMed ID: 21474197
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
Rolfo C; Sortino G; Smits E; Passiglia F; Bronte G; Castiglia M; Russo A; Santos ES; Janssens A; Pauwels P; Raez L
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1173-87. PubMed ID: 25148289
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor vaccine in non-small-cell lung cancer.
Gonzalez Marinello GM; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2012 Apr; 12(4):439-45. PubMed ID: 22500681
[TBL] [Abstract][Full Text] [Related]
7. Updates on immunotherapy in non-small cell lung cancer.
Shimanovsky A; Dasanu CA
Expert Opin Biol Ther; 2014 Apr; 14(4):411-8. PubMed ID: 24512518
[TBL] [Abstract][Full Text] [Related]
8. Vaccines in non-small cell lung cancer: rationale, combination strategies and update on clinical trials.
De Pas T; Giovannini M; Rescigno M; Catania C; Toffalorio F; Spitaleri G; Delmonte A; Barberis M; Spaggiari L; Solli P; Veronesi G; De Braud F
Crit Rev Oncol Hematol; 2012 Sep; 83(3):432-43. PubMed ID: 22366114
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy and lung cancer: current developments and novel targeted therapies.
Domingues D; Turner A; Silva MD; Marques DS; Mellidez JC; Wannesson L; Mountzios G; de Mello RA
Immunotherapy; 2014; 6(11):1221-35. PubMed ID: 25496336
[TBL] [Abstract][Full Text] [Related]
10. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials targeting lung cancer with active immunotherapy: the scope of vaccines.
Raez LE; Santos ES; Mudad R; Podack ER
Expert Rev Anticancer Ther; 2005 Aug; 5(4):635-44. PubMed ID: 16111464
[TBL] [Abstract][Full Text] [Related]
12. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Hall RD; Gray JE; Chiappori AA
Cancer Control; 2013 Jan; 20(1):22-31. PubMed ID: 23302904
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination.
Van den Heuvel MM; Burgers SA; van Zandwijk N
Clin Lung Cancer; 2009 Mar; 10(2):99-105. PubMed ID: 19362952
[TBL] [Abstract][Full Text] [Related]
14. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.
Socinski MA
Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469
[No Abstract] [Full Text] [Related]
15. Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
Acres B
J BUON; 2007 Sep; 12 Suppl 1():S71-5. PubMed ID: 17935281
[TBL] [Abstract][Full Text] [Related]
16. Is vaccine therapy a renewed strategic approach for non-small-cell lung cancer therapy?
Rossi A
Expert Rev Vaccines; 2013 Jan; 12(1):5-7. PubMed ID: 23256734
[No Abstract] [Full Text] [Related]
17. New strategies in lung cancer: translating immunotherapy into clinical practice.
Forde PM; Kelly RJ; Brahmer JR
Clin Cancer Res; 2014 Mar; 20(5):1067-73. PubMed ID: 24470514
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for non-small-cell lung cancer.
Thomas A; Jakopovic M
Expert Opin Biol Ther; 2014 Aug; 14(8):1061-4. PubMed ID: 24878420
[TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint therapy for non-small-cell lung cancer: an update.
Xia B; Herbst RS
Immunotherapy; 2016; 8(3):279-98. PubMed ID: 26860624
[TBL] [Abstract][Full Text] [Related]
20. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
